(PRNewsfoto/Chiesi Global Rare Diseases) Aliada Therapeutics - Boston-based companies will collaborate on in vivo studies testing delivery modules harnessing transferrin and CD98 receptors - BOSTON, Aug. 15, 2023 /PRNewswire/ -- Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people living with rare diseases, today announced a co-development agreement with Aliada Therapeutics, a biotechnology company developing a